Charles Schwab’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,429
| Closed | -$47K | – | 3692 |
|
|
2022
Q1 | $47K | Sell |
2,429
-628
| -21% | -$12.2K | ﹤0.01% | 3537 |
|
|
2021
Q4 | $110K | Hold |
3,057
| – | – | ﹤0.01% | 3427 |
|
|
2021
Q3 | $225K | Sell |
3,057
-318
| -9% | -$23.4K | ﹤0.01% | 3307 |
|
|
2021
Q2 | $471K | Sell |
3,375
-431
| -11% | -$60.1K | ﹤0.01% | 3183 |
|
|
2021
Q1 | $1.11M | Buy |
+3,806
| New | +$1.11M | ﹤0.01% | 2819 |
|